[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100552605":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":15,"centralContacts":20,"locations":25,"responsibleParty":42,"collaborators":7,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":7,"eligibilityCriteria":50,"healthyVolunteers":46,"sex":51,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":7,"studyType":57,"phases":7,"briefSummary":58,"conditions":59,"keywords":63,"overallStatus":28,"whyStopped":7,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":13},"DEVICE","Tissue Oximetry with ForeSight","Evaluation of a correlation between average intraoperative muscle tissue oximetry and postoperative renal damage in patients undergoing cytoreductive surgery with HIPEC for ovarian cancer",[14],"Hemodynamics parameters with Hemosphere",[16],{"name":17,"affiliation":18,"role":19},"Stefano Catarci, MD","FPG IRCCS","PRINCIPAL_INVESTIGATOR",[21],{"name":17,"role":22,"phone":23,"phoneExt":7,"email":24},"CONTACT","0630153744","stefano.catarci@policlinicogemelli.it",[26],{"facility":27,"status":28,"city":29,"state":7,"zip":7,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Policlinico \"A. Gemelli\" IRCCS","RECRUITING","Rome","Italy","IT",{"type":33,"coordinates":34},"Point",[35,36],12.51133,41.89193,{"lat":36,"lon":35},[39,41],{"name":17,"role":22,"phone":40,"phoneExt":7,"email":24},"06 3015 3744",{"name":17,"role":19,"phone":7,"phoneExt":7,"email":7},{"type":43,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100552605","tissue-oximetrys-measurement-in-cytoreductive-surgery-with-hyperthermic-intraperitoneal-chemotherapy-100552605",false,"NCT06475261","Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy","Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy: Prospective Observational Study With Device","Inclusion Criteria:\n\n* American Society Anesthesiologists (ASA) Classification 1-2\n* Cytoreductive surgery for ovarian cancer with laparoscopic or laparotomic technique with Hypertermic Intraperitoneal Chemotherapy.\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years\n* ASA \\> or = 3\n* Cytoreductive surgery without hyperthermic intraperitoneal chemotherapy","FEMALE","18 Years","75 Years",{"count":55,"type":56},50,"ESTIMATED","OBSERVATIONAL","Tissue oximetry obtained from peripheral muscle measures the state of tissue oxygenation of various organs and, as already widely described in the literature, can be used to measure the state of kidney's tissue oxygenation. However, there is no evidence in the existing scientific literature on the use of muscle tissue oximetry in patients undergoing cytoreductive surgery for ovarian cancer with hyperthermic intraperitoneal chemotherapy.\n\nThe primary objective of our study is to evaluate whether there is a correlation between average intraoperative muscle tissue oximetry below 65% (a value which is considered critical in the literature for the resulting cellular damage) and postoperative renal damage in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for ovarian cancer.",[60,61,62],"Oxygen Deficiency","Acute Kidney Injury","Ovarian Carcinoma",[64,65,61,66],"Tissue Oximetry","Hyperthermic Intraperitoneal Chemotherapy","Hemodynamics parameters","2025-03-05",{"date":69,"type":70},"2025-03-07","ACTUAL",{"date":72,"type":70},"2024-07-27",{"date":74,"type":56},"2025-09-30",{"name":5,"class":6},1]